BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Leica Microsystems Acquires Genetix Group plc (GTX.L) Strengthening Life Science Technologies Portfolio


3/11/2010 12:09:21 PM

New Milton, Hampshire, UK/Wetzlar, Germany, 11th March 2010 – Genetix Ltd, a leading provider of solutions for imaging and image analysis, has been acquired by Leica Microsystems.

This acquisition brings together Genetix’ expertise in developing and marketing imaging systems and software for clinical and research applications, with Leica Microsystems’ microscopes and other life science instrumentation. The merger will enable both companies to fully realise their potential through the combination of their ideally complemented skill sets.

Genetix will exist as a separate business unit within Leica Microsystems and Genetix products will continue to be marketed and sold through existing channels. Customer services such as product ordering, applications support and instrument service for Genetix products will remain unchanged.

Commenting on the acquisition Charles de Rohan, Head of Genetix Business Unit within Leica Microsystems, said: “Joining together with Leica Microsystems gives Genetix greater access to global markets and increased financial resources to achieve its growth plans. Over the past decade Genetix has been building its presence in the life sciences, diagnostics and digital pathology segments through a combination of internal product development and acquisitions. Combining our strengthening presence with Leica Microsystems’ R&D capabilities, greater resources and global reach is in the best interests of our shareholders, customers and employees and will maximise the potential of our innovative technology. I would like to take this opportunity to thank all our customers for their continued support."

Stefan Traeger, Managing Director Life Science Division, Leica Microsystems, said: "Genetix’ extensive expertise will be invaluable for us. Their software capabilities, specifically in analytical software, will help us to make progress in the area of virtual microscopy which is a field we have only recently stepped into. In addition, Genetix’ experience and market leading products in cell biology and genetics will expand our reach into the drug discovery and development markets.”

About Genetix (www.genetix.com)

Headquartered in New Milton, UK, with offices in the UK, US, Germany and Japan, Genetix is an independent business unit within Leica Microsystems. The company provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and clinical markets.

In research, pharmaceutical and biotherapeutic development, Genetix systems continue to establish industry standards in areas such as picking microbial colonies for genomic studies or screening and selection of mammalian cell lines. Other systems use imaging platforms to monitor cell growth, evaluate cellular response and quantify tissue biomarkers.

In the clinical market, Genetix holds a leading position with thousands of systems based on its CytoVision® platform used in cytogenetics laboratories throughout the world.

Through its expertise in robotics, cell and molecular biology, image analysis and interpretation, supported by a strong IP portfolio, Genetix is committed to the continual development of innovative solutions.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES